PEDIATRICS Vol. 98 No. 4 October 1996, pp. 698-705
This Article
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Day, R. W.
Right arrow Articles by Ward, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Day, R. W.
Right arrow Articles by Ward, R. M.

Acute Response to Inhaled Nitric Oxide in Newborns With Respiratory Failure and Pulmonary Hypertension

Ronald W. Day MD1, Joanna M. Lynch RRT2, Keith S. White MD3, and Robert M. Ward MD1

1 Department of pediatrics, Primary Children's Medical Center and University of Utah, Salt Lake City
2 Department of Respiratory Care, Primary Children's Medical Center and University of Utah, Salt Lake City
3 Department of Radiology, Primary Children's Medical Center and University of Utah, Salt Lake City

Objective. Systemic oxygenation is improved by inhaled nitric oxide therapy in some newborns with respiratory failure and pulmonary hypertension. Our results with inhaled nitric oxide were reviewed to determine factors associated with an acute improvement in systemic oxygenation.

Methods. Newborns with oxygenation indices of 25 to 40 were prospectively randomized to receive conventional therapy with or without 20 ppm inhaled nitric oxide. All newborns with oxygenation indices greater than 40 were treated with inhaled nitric oxide. Hemodynamic, blood gas, and Doppler ultrasound measurements were performed before and after 30 to 60 minutes of observation or therapy. The severity of lung disease was classified by the chest radiograph as: (1) normal or focal disease; (2) moderate diffuse disease—diffuse lung disease with well-defined heart borders; or (3) severe diffuse disease—diffuse lung opacification with indistinct heart borders.

Results. Heart rate, blood pressure, and ductal diameters did not change. Blood gases and ductal shunting acutely improved only in patients treated with inhaled nitric oxide. Patients with normal lung fields or focal disease had the greatest degree of improvement in systemic oxygenation. Changes in oxygenation were not influenced by gestational age, baseline blood gases, the proportion of right-to-left ductal shunting, prior treatment with a surfactant, or the use of conventional or high-frequency jet ventilation. Collectively, blood gases and ductal shunting did not improve with inhaled nitric oxide in patients with lung hypoplasia or severe diffuse lung disease. Sustained improvement in oxygenation occurred in 87% of patients with oxygenation indices greater than 40 in whom oxygenation indices less than 40 acutely developed after exposure to nitric oxide, whereas 90% of patients in whom oxygenation indices less than 40 did not acutely develop were treated with extracorporeal membrane oxygenation or ultimately died.

Conclusions. Inhaled nitric oxide acutely improves systemic oxygenation in many newborns with respiratory failure and pulmonary hypertension. The diagnosis and chest radiograph are helpful in identifying patients who will have favorable acute responses to therapy. In patients with severe hypoxemia, the need for invasive support with extracorporeal membrane oxygenation may be determined by an acute trial of inhaled nitric oxide.

Submitted on September 27, 1995
Accepted on December 8, 1995




This article has been cited by other articles:


Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
P. J. McNamara, P. Murthy, C. Kantores, L. Teixeira, D. Engelberts, T. van Vliet, B. P. Kavanagh, and R. P. Jankov
Acute vasodilator effects of Rho-kinase inhibitors in neonatal rats with pulmonary hypertension unresponsive to nitric oxide
Am J Physiol Lung Cell Mol Physiol, February 1, 2008; 294(2): L205 - L213.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
N. Subhedar and C. Dewhurst
Is nitric oxide effective in preterm infants?
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2007; 92(5): F337 - F341.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
R. B. Stuart, B. Ovadia, V. V. Suzara, P. A. Ross, S. Thelitz, J. R. Fineman, and J. A. Gutierrez
Inhaled nitric oxide increases surfactant protein gene expression in the intact lamb
Am J Physiol Lung Cell Mol Physiol, September 1, 2003; 285(3): L628 - L633.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
A. N. MacRitchie, K. H. Albertine, J. Sun, P. S. Lei, S. C. Jensen, A. A. Freestone, P. M. Clair, M. J. Dahl, E. A. Godfrey, D. P. Carlton, et al.
Reduced endothelial nitric oxide synthase in lungs of chronically ventilated preterm lambs
Am J Physiol Lung Cell Mol Physiol, October 1, 2001; 281(4): L1011 - L1020.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
B. Weinberger, D. L. Laskin, D. E. Heck, and J. D. Laskin
The Toxicology of Inhaled Nitric Oxide
Toxicol. Sci., January 1, 2001; 59(1): 5 - 16.
[Abstract] [Full Text] [PDF]

Home page
 PediatricsHome page
Committee on Fetus and Newborn
Use of Inhaled Nitric Oxide
Pediatrics, August 1, 2000; 106(2): 344 - 345.
[Abstract] [Full Text]

Home page
 PediatricsHome page
R. W. Day
Inhaled Nitric Oxide Prevents Severe Hypoxemia in Newborns With Acute Lung Disease and Pulmonary Hypertension
Pediatrics, June 1, 1998; 101 (6): 1093 - 1094.
[Full Text]

Home page
 PediatricsHome page
D. L. Wessel, I. Adatia, L. J. Van Marter, J. E. Thompson, J. W. Kane, A. R. Stark, and S. Kourembanas
Improved Oxygenation in a Randomized Trial of Inhaled Nitric Oxide for Persistent Pulmonary Hypertension of the Newborn
Pediatrics, November 1, 1997; 100(5): e7 - e7.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
N. FINER
Inhaled nitric oxide in neonates
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 1997; 77(2): 81F - 84.
[Full Text]

Home page
 NEJMHome page
J. D. Roberts, J. R. Fineman, F. C. Morin, P. W. Shaul, S. Rimar, M. D. Schreiber, R. A. Polin, M. S. Zwass, M. M. Zayek, I. Gross, et al.
Inhaled Nitric Oxide and Persistent Pulmonary Hypertension of the Newborn
N. Engl. J. Med., February 27, 1997; 336(9): 605 - 610.
[Abstract] [Full Text] [PDF]